MFG
BNGO icon

Merit Financial Group’s Bionano Genomics BNGO Stock Holding History

Merit Financial Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-18
Closed -$6.71K – 744
2023
Q2 		$6.71K Hold
18
– – ﹤0.01% 744
2023
Q1 		$12.2K Hold
18
– – ﹤0.01% 627
2022
Q4 		$16.1K Hold
18
– – ﹤0.01% 680
2022
Q3 		$20K Hold
18
– – ﹤0.01% 559
2022
Q2 		$15K Hold
18
– – ﹤0.01% 566
2022
Q1 		$28K Buy
+18
New +$24.3K ﹤0.01% 377

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Merit Financial Group's BNGO Position: Q3 2023 in Review

Merit Financial Group sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 18 shares — an estimated $6.71K sold.

Merit Financial Group first reported a position in BNGO in Q1 2022 and held it in 6 quarters. The position peaked at $28K in Q1 2022. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Merit Financial Group reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Merit Financial Group sold 18 Bionano Genomics shares in Q3 2023, an estimated $6.71K.
  • Merit Financial Group first reported a position in Bionano Genomics in Q1 2022 and held it in 6 quarters.
  • Merit Financial Group's Bionano Genomics position peaked at $28K in Q1 2022.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Merit Financial Group's 13F filing for Q3 2023, filed 7 Nov 2023.